Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation)
Clinical trial NCT02690519 · COMPLETED
Trial details
- NCT number
- NCT02690519
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.